BNP PARIBAS FINANCIAL MARKETS - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 218 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q2 2024$37,282
-81.6%
10,299
-83.7%
0.00%
Q1 2024$202,683
-2.5%
63,141
+48.8%
0.00%
Q4 2023$207,912
-50.9%
42,431
-45.4%
0.00%
-100.0%
Q3 2023$423,808
+111.9%
77,763
+160.9%
0.00%
Q2 2023$200,005
-65.4%
29,807
-54.5%
0.00%
-100.0%
Q1 2023$578,383
+91.4%
65,502
+65.6%
0.00%
Q4 2022$302,154
-99.9%
39,549
-53.0%
0.00%
-100.0%
Q3 2022$598,529,000
+94.9%
84,063
+121.4%
0.00%
Q2 2022$307,161,000
+160.8%
37,968
+347.5%
0.00%
Q1 2022$117,772,000
+34.3%
8,485
+171.4%
0.00%
Q4 2021$87,716,000
-17.4%
3,126
+0.1%
0.00%
Q3 2021$106,151,000
+55.0%
3,123
+86.3%
0.00%
Q2 2021$68,481,000
-48.9%
1,676
-49.7%
0.00%
Q1 2021$134,106,000
-17.1%
3,331
+21.7%
0.00%
Q4 2020$161,839,000
+182.0%
2,737
+131.9%
0.00%
Q3 2020$57,383,000
-59.8%
1,180
-60.1%
0.00%
Q2 2020$142,915,000
+218.7%
2,954
+83.0%
0.00%
Q1 2020$44,837,000
+89.9%
1,614
+104.6%
0.00%
Q4 2019$23,607,000
+14.0%
789
+17.8%
0.00%
Q3 2019$20,703,0006700.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2021
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 1,687,665$5,417,4055.10%
Rubric Capital Management LP 10,500,000$33,705,0001.00%
Triatomic Management LP 98,555$316,3620.59%
Pier Capital, LLC 1,103,441$3,542,0460.49%
Newtyn Management, LLC 623,690$2,002,0450.40%
VIKING GLOBAL INVESTORS LP 29,993,708$96,279,8030.36%
Matrix Capital Management Company, LP 11,572,590$37,148,0140.34%
Tejara Capital Ltd 269,014$863,5350.32%
Aristotle Atlantic Partners, LLC 2,992,563$9,606,1270.31%
DDD Partners, LLC 739,739$2,374,5620.29%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders